OUR OUR
40 th
V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER
YEAR YEAR
ISSN 1068-1760
Vol.40 No.6 • 10/2023
DAILY CLINICAL LAB NEWS
®
I
N
T
Test Improves MS Management ultiple sclerosis (MS) is a complex ailment with considerable diversity, impacting each patient uniquely, which complicates diagnosis and prognosis. Effectively managing disease activity, which involves new neurological symptoms and re-
M
E
R
N
A
T
I
O
N
A
L
New STI Testing Guidelines to Render Low-Cost POC Diagnostics More Accessible
Method Eliminates Renal Biopsies
very day, over one million individuals contract new sexually transmitted infections (STIs), marking a significant global health concern. The COVID-19 pandemic saw a dip in STI prevention, testing, and treatment services in numerous countries,
L
E
resulting in a worldwide STI resurgence. Nations with robust STI surveillance like the US and UK have witnessed a rise in STIs. The emergence of infections such as mpox and the resurgence of neglected STIs challenge prevention and control efforts. There’s
Cont’d on page 3
Cont’d on page 13
Antimicrobial Resistance: New Insights into Evolution Call for Shifts in Testing
upus (systemic lupus erythematosus, or SLE) is a serious autoimmune disease that has the potential to affect various organs and even result in death. A particularly severe complication of lupus is lupus nephritis (LN), which is a severe inflammation of the kidneys. This condition can be fatal, as it is a leading cause of death among lupus patients. Between 5% and 20% of the 60% Cont’d on page 11
Improved Malaria Detection in Blood very year, over 200 million individuals contract malaria, with more than half a million of these cases resulting in fatalities. The World Health Organization advocates for the use of parasite-based diagnosis prior to commencing treatment for the infectious disease caused by Plasmodium parasites. Various diagnostic techniques are available, including conventional light
E
latest study shows that patients often get co-infected by multiple clones of pathogens and that resistance arises from the selection of already resistant clones rather than new mutations.
A
See article on page 7
Cont’d on page 10 V
I
S
I
LINKXPRESS COM R E A D E R
Handheld Immunoassay Analyzer Offers POC Testing Breakthrough
T
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription
A
Instant Online Product Information: ®
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress ® inquiry matrix If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
POC Testing Update . . . 4
n automated, compact, and affordable fluorescent Immunoassay (FIA) solution is designed to transform the landscape of clinical point-of-care (POC) diagnostics. The innovative analyzer is capable of detecting a broad spectrum of analytes, such as hormones, enzymes, and infectious
Access Interactive Digital Magazine
Identify LinkXpress codes of 1 interest as you read magazine
INSIDE
Cont’d on page 14
Rapid Blood Test Detects and Distinguishes 18 Infectious or Inflammatory Diseases nfectious and inflammatory diseases often bring children into hospitals and clinics for medical care. The challenge for healthcare professionals lies in accurately differentiating between potentially severe bacterial infections and less critical ailments, especially
I
when symptoms such as fever are common to many illnesses. As a result, many patients might receive broad-spectrum antibiotics as a precautionary measure until bacterial infection is ruled out. This overuse of antibiotics contributes to antimicrobial resisCont’d on page 15
LabMedica EXPO . 6-16 Clinical News . . . . 3-16 IFCC News . . . . 17-20 Industry News .. . . . 21 Events Calendar . . 22 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<